Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial.

Shen, Qiu-Dan

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial. [electronic resource] - The Lancet. Haematology Jun 2018 - e261-e269 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

2352-3026

10.1016/S2352-3026(18)30054-1 doi


Aged
Aged, 80 and over
Antigens, CD20
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Deoxycytidine--administration & dosage
Disease-Free Survival
Female
Humans
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Middle Aged
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Rituximab--administration & dosage
Treatment Outcome
Gemcitabine